| Muscle Invasive Bladder Carcinoma studied in …STUDIED_INderived65 of 65show fewer |
|---|
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061964Phase 2 · recruiting Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290687Phase 2 · withdrawn Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605404recruiting Pan-tumor MRD Study · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04506554Phase 2 · active not recruiting A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06529822Phase 1 · recruiting Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332351Phase 2 · not yet recruiting Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822373Phase 2 · not yet recruiting A Phase 2 Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821177early Phase 1 · active not recruiting Bladder Preservation or Cystectomy for MIBC · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334069recruiting Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03775265Phase 3 · active not recruiting Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07579195Phase 1/Phase 2 · recruiting Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097142Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05776758Phase 3 · active not recruiting Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07726602recruiting Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06417190Phase 2 · recruiting Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06809140Phase 2 · recruiting Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05833867Phase 1 · recruiting Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06204614early Phase 1 · enrolling by invitation Drug Screening Using IMD in Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05581589Phase 2 · terminated Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05700227NA · terminated Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07525349not yet recruiting Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05406713Phase 2 · active not recruiting Pembrolizumab in Muscle-invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05295992NA · active not recruiting Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04610671Phase 1 · completed Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470282Phase 1/Phase 2 · recruiting Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07234968NA · recruiting Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339761NA · recruiting Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07279597Phase 2 · not yet recruiting A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263153Phase 2 · recruiting Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05975307Phase 2 · active not recruiting Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05630131completed ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06537960NA · recruiting Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06190197early Phase 1 · recruiting Prophylactic Antibiotics in Cystectomy With Diversion · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06396533recruiting Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564416Phase 2 · withdrawn Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04383743Phase 2 · completed Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06571708Phase 2 · recruiting Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT) · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06537154Phase 2/Phase 3 · recruiting NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05028660completed AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06257017Phase 2 · recruiting Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06493552Phase 2/Phase 3 · recruiting Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04724928Phase 2 · recruiting Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04871529Phase 2 · terminated Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL) · condition mapped ALIAS · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05790850NA · recruiting Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial) · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06341400Phase 1/Phase 2 · recruiting RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05203913Phase 2 · recruiting Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06215976Phase 4 · unknown The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528483Phase 2 · not yet recruiting Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06325423not yet recruiting Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05297552Phase 2 · unknown A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06170177recruiting Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06074484Phase 2 · unknown A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05767528unknown Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05221827terminated Clinical Performance Evaluation of the C2i-Test · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03617913Phase 2 · completed Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04598724completed Addressing Barriers to Palliative Care Use in Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05395260early Phase 1 · withdrawn FL- 101 Study in Non-Metastatic MIBC · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04876313Phase 2 · unknown An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo) · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05097404unknown Clinical Utility of VI-RADS in Diagnosis of MIBC · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04966130unknown Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder. · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04909775Phase 2 · unknown Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04900558recruiting Robotic Radical Cystectomy Outcomes · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04686149unknown a Genome-based Platform to Predict Patients That Can Achieve Bladder Preservation in Muscle Invasive Bladder Cancer Patients · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02145390NA · terminated Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy · condition mapped ONTOLOGY_EXACT · 65 trials mapped (42 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |